期刊文献+

血管形成与膀胱癌分级及复发相关性研究 被引量:1

Study of the Relativity between MVD and Histopathological Grade and Recurrence in Transitional Cell Carcinoma of Bladder
下载PDF
导出
摘要 目的 观察膀胱癌微血管密度 (MVD)及碱性成纤维细胞生长因子 (bFGF)与膀胱癌分级及复发的关系。方法 本组膀胱移行细胞癌患者 6 2例 ,年龄 36~ 82岁 ,平均 6 5岁。采用免疫组织化学染色CD34观察膀胱癌组织中MVD以及bFGF的表达情况。结果 G1级、G2级、G3膀胱癌中bFGF阳性率分别为 33.3%、4 8%、73.7% ,其中 ,G1级与G3级膀胱癌间差异有统计学意义 (P <0 .0 5 )。膀胱癌复发组及未复发组bFGF阳性率分别为 73.1%、36 .1%(P <0 .0 5 )。G1级、G2级、G3膀胱癌MDV分别为 4 4 .3± 11.6、5 3.5± 10 .6、71.9± 15 .3,G1级与G3级膀胱癌间差异有统计学意义 (P <0 .0 5 )。膀胱癌复发组及未复发组MDV分别为 4 1.7± 10 .9、77.2± 15 .3(P <0 .0 5 )。结论 膀胱癌bFGF表达及MVD与其分级及肿瘤复发相关 。 Objective To observe the relationship of MVD with histopathological grade and recurrence in transitional cell carcinoma of bladder(TCCB).Methods Observation was given to 62 patients with TCCB;CD34 and basic fibroblast growth factor(bFGF)were detected by immunohistochemical assay in tissues of TCCB and imcrovessel density(MVD)was analyzed by staining with antibodies to CD34.Results The positive rates of bFGF were 33.3%,48%,73.7% in tissues of G1,G2,G3,TCCB while those in tissues of primary group and recurrent group were 73.1% and 36.1%(P<0.05);the MVDs were 44.3±11.6,53.5±10.6,71.9±15.3 in tissues of G1,G2,G3,TCCB and those of primary group and recurrent group were 41.7±10.9,77.2±15.3(P<0.05).Conclusion This study indicates that MVD and bFGF are closely related to the histopathological grade and recurrence of TCCB;MVD has prognostic value on TCCB
出处 《西南军医》 2004年第6期1-3,共3页 Journal of Military Surgeon in Southwest China
关键词 膀胱肿瘤 血管形成 碱性成纤雏细胞生长因子 bladder neoplasm microvessel density basic fibroblast growth factor
  • 相关文献

参考文献2

二级参考文献1

共引文献4

同被引文献6

  • 1Rodriguez-Alonso A,Pita-Fernandez S,Gonzalez-Carrero J,et al.Multivariate analysis of survival,recurrence,progression and development of metastasis in T1 and T2a transitional cell bladder carcinoma[J].Cancer,2002,94(6):1677-1684.
  • 2Denkbas EB,zdemyr N,zturk E.Mitomycin-C-loaded alginate carriers for bladder cancer chemotherapy[J].Bioact Compat Polym,2004,19(1):33-44.
  • 3Schrag D,Hsieh LJ,Rabbani F,et al.Adherence to surveillance among patients with superficial bladder cancer[J].J Natl Cancer Inst,2003,95(8):588-597.
  • 4Giannopoulos A,Constantinides C,Fokaeas E,et al.The immunomodulating effect of interferon-γ intravesical instillations in preventing bladder cancer recurrence[J].Clin Cancer Res,2003,9(15):5550-5558.
  • 5Dalbagni G,Russo P,Sheinfeld J,et al.Phase Ⅰ trial of intravesical gemcitabine in bacillus Calmette-Guérin refractory transitional-cell carcinoma of the bladder[J].J Clin Oncol,2002,20(15):3193-3198.
  • 6魏强,唐孝达,杨宇如,李虹,张卫东,陈宗福.影响膀胱肿瘤术后复发的 COX 回归模型多因素分析[J].中华泌尿外科杂志,1997,18(3):162-165. 被引量:17

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部